The Korean branch of the American multinational biotech Biogen, has selected Hwang Se-eun as its new CEO. Hwang is expected to drive the growth of the company with her experience in the domestic and overseas pharmaceutical market.

Hwang graduated from Chung-Ang University College of Pharmacy and obtained her masters at Sogang Business School. She has worked at various pharmaceutical companies such as JW Pharmaceutical, MSD Korea, Abbott Korea, and Handok.

Biogen Korea established its Korean branch in July, having created Samsung Bioepis as a joint venture with Samsung BioLogics in 2012.

Biogen Korea intends to achieve growth by securing a firm place in the domestic healthcare market. The company will concentrate all its capabilities to become a trustworthy partner by creating an environment where more patients will be able to get treated quickly.